Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Patent
1993-02-09
1995-12-19
Sidberry, Hazel F.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
530350, 5303881, 435 691, 4241851, 4242551, 4242821, A61K 3900, A61K 39102, A61K 4500, C07K 1504
Patent
active
054766575
ABSTRACT:
New proteins and subunit antigens from P. haemolytica for use in stimulating immunity against respiratory diseases such as pneumonia, including shipping fever pneumonia, are disclosed. The subunit antigens include immunogenic amino acid sequences of P. haemolytica fimbrial protein, P. haemolytica plasmin receptor protein, and P. haemolytica 50K outer membrane protein and P. haemolytica leukotoxin. The antigens can be used in a vaccine composition, either alone or in combination. Also disclosed are methods of vaccination as well as methods of making the subunit antigens employed in the vaccines.
REFERENCES:
patent: 4957739 (1990-09-01), Berget et al.
patent: 5028423 (1991-07-01), Prickett et al.
patent: 5055400 (1991-10-01), Lo et al.
patent: 5165924 (1992-11-01), Shewen et al.
Ludwig et al Mol Gen Genetics 206:238-245, 1987. Mutations Affecting Activity and Transport of Haemolysin in Escherichia coli: (1).
Gruz et al Mol. Microbiol, Deletion Analysis Resolves Cell-Binding and Lytic Domains of the Pasteurella Leukotoxin 4:1933-1939, 1990.
Strathdee et al. Infect. & Immunity 55:3233-3236 1987 "Extensive Homology Between the Leukotoxin of Pasteurella haemolytica A1 and the Alpha-Hemolysin of Escherichia coli".
Feimlee et al Proc Natl Acad Sci. 85: 5269-5273 1988. Alterations of Amino Acids Repeats in the E coli Hemolysin Affect Cytolytic Activity & Secretion.
Nicaud et al FEBS Letters 187:339-344 1985 Characterisation of HlyC and Mechanism of Activation and Secretion of Haemolysin from E coli 2001.
Forestier et al Infect & Immunity 58:828-832 1990 Nonreciprocal Complementation of the HylC & LkTC Genes of the E. coli Hemolysin and P haemolytica Leukutoxin Determinants.
Shewen et al Can. J. Res 52:30-36 1988 Vaccination of Calves with Leukotoxic Cultures Supernantant from P. haemolytica.
Highlander DNA 8:15-20 1989, DNA Sequence of the Pasteurella haemolytica Leukotoxin Gene Cluster.
Ludwig et al Mol Gen Genet 214: 553-561, 1988 The Repeat Domain of Escherichia coli Haemolysin (HlyA) is Responsible for Its Ca.sup.2+ -Dependent Binding Erythrocytes (2).
Lo et al, Infect and Immunity 55:1987-1996, 1987 Nucleotide Sequence of the Leukotoxin Genes of Pasteurella haemolytica A1.
Cavalieri et al., "Escherichia coli .alpha.-hemolysin: Characteristics and probable role in pathogenicity" Microbiol. Reveiws (1984) 48:326-343.
Frey et al., "Acinobacillus pleuropneumoniae RTX-toxins: uniform designation of haemolysins, cytolysins, pleurotoxin and their genes" J. Gen. Microbiol. (1993) 139:1723-1728.
Simpson et al., "Killing of human myelomonocytic leukemia and lymphocytic cell lines by Actinobacillus actinomycetemcomitans leukotoxin" Infect. Immun. (1988) 56:1162-1166.
Taichman et al., "Cytopathic effects of Actinobacillus actinomycetemcomitans on monkey blood leukocytes" J. Peridon. Res. (1984) 19:133-145.
Welch, R. A., "Pore-forming cytolysins of Gram-negative bacteria" Mol. Microbiol. (1991) 5:521-528.
Conlon et al., Infect. Immun. (1991) 59:587-591.
Gentry et al., Vet. Immunology and Immunopathology (1985) 9:239-250.
Himmel et al., Am. J. Vet. Res. (1982) 43:764-767.
Lo et al., Infect. Immun. (1985) 50:667-67.
Shewen, P. E. and Wilkie, B. N., Infect. Immun. (1982) 35:91-94.
Shewen, P. E. and Wilkie, B. N., Am. J. Vet. Res. (1983) 44:715-719.
Sutherland et al., Vet. Microbiol. (1989) 19:175-181.
Yates, W. D. G., Can. J. Comp. Med. (1982) 46:225-263.
Biostar Brochure, entitled "3 New Vaccines", released on 6 Jul. 1991.
Baluyut et al., Am. J. Vet. Res. (1981) 42:1920-1926.
Sidberry Hazel F.
University of Saskatchewan
LandOfFree
Pasteurella haemolytica leukotoxin compositions and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pasteurella haemolytica leukotoxin compositions and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pasteurella haemolytica leukotoxin compositions and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-990686